Evidence map›Paper›PMID 33771977›Full record

ArticleCell death & disease2021

Cytoplasmic DNA accumulation preferentially triggers cell death of myeloid leukemia cells by interacting with intracellular DNA sensing pathway.

Tomohisa Baba, Takeshi Yoshida, Yamato Tanabe, Tatsunori Nishimura, Soji Morishita, Noriko Gotoh, Atsushi Hirao, Rikinari Hanayama, Naofumi Mukaida

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Molecular and Clinical Insights intoInternational journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tomohisa BabaDivision of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan. sergenti@staff.kanazawa-u.ac.jp.ORCID 0000-0002-2161-2087
Takeshi YoshidaDepartment of Immunology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Yamato TanabeDivision of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
Tatsunori NishimuraDivision of Cancer Cell Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
Soji MorishitaDepartment of Transfusion Medicine and Stem Cell Regulation, Juntendo University School of Medicine, Tokyo, Japan.
Noriko GotohDivision of Cancer Cell Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.ORCID 0000-0003-3733-260X
Atsushi HiraoNano Life Science Institute, Kanazawa University, Kanazawa, Japan.
Rikinari HanayamaDepartment of Immunology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Naofumi MukaidaDivision of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.ORCID 0000-0002-4193-1851
Kanazawa University · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence indicates the presence of cytoplasmic DNAs in various types of malignant cells, and its involvement in anti-cancer drug- or radiotherapy-mediated DNA damage response and replication stress. However, the pathophysiological roles of cytoplasmic DNAs in leukemias remain largely unknown. We observed that during hematopoietic stem cell transplantation (HSCT) in mouse myeloid leukemia models, double-stranded (ds)DNAs were constitutively secreted in the form of extracellular vesicles (EVs) from myeloid leukemia cells and were transferred to the donor cells to dampen their hematopoietic capabilities. Subsequent analysis of cytoplasmic DNA dynamics in leukemia cells revealed that autophagy regulated cytoplasmic dsDNA accumulation and subsequent redistribution into EVs. Moreover, accumulated cytoplasmic dsDNAs activated STING pathway, thereby reducing leukemia cell viability through reactive oxygen species (ROS) generation. Pharmaceutical inhibition of autophagosome formation induced cytoplasmic DNA accumulation, eventually triggering cytoplasmic DNA sensing pathways to exert cytotoxicity, preferentially in leukemia cells. Thus, manipulation of cytoplasmic dsDNA dynamics can be a novel and potent therapeutic strategy for myeloid leukemias.

Indexed as

AnimalsCell DeathDNAHumansLeukemia, MyeloidMaleMiceTransfectionDNA

Identifiers

PMID33771977
PMCPMC7997981
OpenAlexW3137234634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.